ZA946698B - Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs - Google Patents

Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs

Info

Publication number
ZA946698B
ZA946698B ZA946698A ZA946698A ZA946698B ZA 946698 B ZA946698 B ZA 946698B ZA 946698 A ZA946698 A ZA 946698A ZA 946698 A ZA946698 A ZA 946698A ZA 946698 B ZA946698 B ZA 946698B
Authority
ZA
South Africa
Prior art keywords
drugs
administration
homeopathic
medical device
active ingredients
Prior art date
Application number
ZA946698A
Other languages
English (en)
Inventor
Paolo Dr Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of ZA946698B publication Critical patent/ZA946698B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA946698A 1993-09-02 1994-09-01 Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs ZA946698B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (1)

Publication Number Publication Date
ZA946698B true ZA946698B (en) 1995-05-02

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946698A ZA946698B (en) 1993-09-02 1994-09-01 Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs

Country Status (12)

Country Link
US (1) US5683712A (ko)
EP (1) EP0641561B1 (ko)
JP (1) JPH07165566A (ko)
KR (1) KR950007808A (ko)
AT (1) ATE173162T1 (ko)
CA (1) CA2129760A1 (ko)
DE (1) DE69414502T2 (ko)
DK (1) DK0641561T3 (ko)
ES (1) ES2125380T3 (ko)
GR (1) GR3029308T3 (ko)
IT (1) IT1261849B (ko)
ZA (1) ZA946698B (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
HUE054852T2 (hu) 2005-12-01 2021-10-28 Univ Massachusetts Lowell Botulinum nanoemulziók
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
WO2008039245A2 (en) 2006-04-27 2008-04-03 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
EP2395021A1 (en) * 2006-06-06 2011-12-14 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
AU2007329579A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
CN107080703A (zh) 2006-12-01 2017-08-22 安特里奥公司 肽纳米粒子和其用途
AU2008228903B2 (en) 2007-03-19 2013-03-07 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin B12
EP2162117B1 (en) 2007-05-31 2018-02-21 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
CN105147608B (zh) 2008-06-26 2019-12-10 安特里奥公司 真皮递送
SG187035A1 (en) 2010-07-15 2013-02-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
JP2013532182A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
FR2962656A1 (fr) 2010-07-15 2012-01-20 Oleg Iliich Epshtein Procede pour augmenter l'effet d'une forme activee-potentialisee d'un anticorps
WO2012010238A1 (en) 2010-07-17 2012-01-26 Merck Patent Gmbh Enhancement of penetration and action
MX2013000807A (es) 2010-07-21 2013-10-28 Oleg Iliich Epshtein Un metodo para el tratamiento del trastorno de hiperactividad con deficit de atencion.
ITTO20110638A1 (it) 2010-07-21 2012-01-22 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori
US20120328549A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Oil compositions
SG193970A1 (en) 2011-01-24 2013-11-29 Anterios Inc Nanoparticle compositions
US20120328701A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
AU2012223195A1 (en) * 2011-03-03 2013-10-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
KR101802011B1 (ko) 2011-03-10 2017-11-27 리겔 파마슈티칼스, 인크. 원반성 루푸스에 사용하기 위한 2,4 치환 피리미딘디아민
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) * 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
WO2014043257A1 (en) 2012-09-12 2014-03-20 Rigel Pharmaceuticals, Inc. Treatment for vitiligo
CA2907915C (en) 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
US9649266B2 (en) 2014-05-01 2017-05-16 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
BR112018001376A2 (pt) 2015-07-24 2018-09-11 Glaxo Group Ltd tratamento para vitiligo
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
AU2018389104A1 (en) 2017-12-20 2020-07-30 Allergan, Inc. Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation
US20220105068A1 (en) 2018-09-13 2022-04-07 Eirion Therapeutics, Inc. Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
BR112021004550A2 (pt) 2018-09-13 2021-06-08 Eirion Therapeutics, Inc. usos de inibidores de inibidor de ativador de plasminogênio 1 (pai-1)
JP2022510007A (ja) 2018-12-03 2022-01-25 エイリオン セラピューティクス， インコーポレイテッド 大型薬物の送達改善
EP3969038A1 (en) 2019-05-14 2022-03-23 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
KR950007808A (ko) 1995-04-15
DE69414502T2 (de) 1999-04-08
CA2129760A1 (en) 1995-03-03
US5683712A (en) 1997-11-04
GR3029308T3 (en) 1999-05-28
JPH07165566A (ja) 1995-06-27
ATE173162T1 (de) 1998-11-15
DE69414502D1 (de) 1998-12-17
IT1261849B (it) 1996-06-03
EP0641561A3 (en) 1995-09-27
ES2125380T3 (es) 1999-03-01
ITRM930591A0 (it) 1993-09-02
ITRM930591A1 (it) 1995-03-02
EP0641561B1 (en) 1998-11-11
DK0641561T3 (da) 1999-07-26
EP0641561A2 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
GR3029308T3 (en) Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs.
US4615699A (en) Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
DE69121881D1 (de) Hautelektrodenaufbau und dazugehöriges gerät zur transdermalen verabreichung von heilmitteln
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
DK567088D0 (da) Indretning til transdermal laegemiddelindgift
DK0831827T3 (da) Nye formuleringer til transdermal levering af pergolid
PL330212A1 (en) Preparation administered by transcutaneous absorption
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
SE9301877D0 (sv) In situ gel for therapeutic use
NO155620C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.